3D Biological Printing

3D Biological Printing Market Outlook

The global 3D biological printing market is projected to reach USD 2.5 billion by 2035, growing at a robust CAGR of 22.5% from 2025 to 2035. This impressive growth can be attributed to several factors such as advancements in technology, increasing demand for organ transplantation, and the rising adoption of 3D bioprinting in various applications like drug discovery and regenerative medicine. Additionally, the growing focus on personalized medicine is expected to further fuel the market's expansion as researchers and healthcare providers seek innovative solutions to improve patient outcomes. Furthermore, increased investments in research and development from both private and public sectors are driving the creation of more sophisticated bioprinting technologies, paving the way for broader adoption in healthcare and beyond.

Growth Factor of the Market

One of the primary growth factors for the 3D biological printing market is the rising prevalence of chronic diseases and the need for personalized treatment options. As the global population ages, the demand for organ transplants and tissue engineering solutions continues to increase, highlighting the importance of innovation in this field. Moreover, the integration of artificial intelligence and machine learning within bioprinting processes is bringing about significant enhancements in efficiency and accuracy, allowing for more complex tissue structures to be created. The pharmaceutical industry is also recognizing the potential of 3D biological printing for drug discovery, as it enables more effective testing of drug responses and toxicity in patient-specific environments. Furthermore, the expansion of research initiatives and funding from various government agencies and private organizations is propelling advancements in bioprinting technologies, thus broadening the scope of applications and driving market growth.

Key Highlights of the Market

• The market is expected to grow at a CAGR of 22.5% between 2025 and 2035.
• North America is predicted to hold the largest market share due to strong R&D initiatives in biological printing technology.
• Increasing demand for organ transplants is driving the application of 3D bioprinting in regenerative medicine.
• The integration of AI technologies is enhancing the efficiency and precision of bioprinting processes.
• Collaboration between academic institutions and biotechnology companies is fostering significant innovations in this sector.

By Application

Tissue Engineering:

Tissue engineering is one of the most promising applications of 3D biological printing, aimed at creating advanced living tissues that can replace or regenerate damaged biological structures. By employing bioprinting technology, researchers can precisely layer cells and biomaterials to form complex tissue scaffolds that mimic the properties of natural tissues. This approach not only enhances the feasibility of transplanting bioengineered tissues but also provides a platform for studying disease mechanisms and testing new drugs. Significant advancements in material biocompatibility and printing techniques have led to improved outcomes in the development of functional tissue constructs, thereby driving growth in this segment.

Regenerative Medicine:

In the realm of regenerative medicine, 3D biological printing plays a critical role in designing and producing tissues and organs that can be used for transplantation. The ability to create patient-specific scaffolds that promote cell growth and tissue integration is revolutionizing the landscape of regenerative therapies. By utilizing 3D bioprinting, medical professionals can tailor treatments to individual patient needs, significantly increasing the chances of successful grafting and minimizing the risk of rejection. Furthermore, ongoing research into the printing of complex organ structures holds the potential for addressing the critical shortage of donor organs, reinforcing the importance of this application in the overall growth of the market.

Drug Discovery:

The drug discovery sector is rapidly adopting 3D biological printing technologies due to their capability to create in vitro models that closely resemble human tissues. These bioprinted models provide a more accurate representation of drug behavior in the human body, allowing researchers to evaluate drug efficacy and safety more effectively. By utilizing 3D bioprinted tissues, pharmaceutical companies can streamline the drug development process, reducing time and costs associated with traditional testing methods. As regulatory bodies increasingly favor the use of advanced models for drug testing, the demand for 3D bioprinting in drug discovery is expected to escalate, further driving market growth.

Biosensors:

3D biological printing is also being utilized in the development of biosensors, which are essential for monitoring various biological processes and detecting diseases at early stages. By incorporating live cells into biosensor designs, researchers can create responsive systems that can provide real-time data on cellular activities and physiological changes. This innovative approach enhances the sensitivity and specificity of biosensors, making them valuable tools for diagnostics and personalized healthcare. As the need for early disease detection and monitoring continues to rise, the integration of bioprinting technologies in biosensor development is anticipated to contribute significantly to market growth.

Food Technology:

In food technology, 3D biological printing is emerging as a groundbreaking method for producing sustainable and customizable food products. This innovative approach allows for the creation of food structures that mimic the taste, texture, and nutritional profile of traditional food items. By using plant-based materials and bio-inks, companies can address growing concerns about food security and sustainability while catering to diverse consumer preferences. The potential to print personalized food products that meet specific dietary needs or preferences is driving interest in this application, resulting in notable growth in the food technology segment of 3D biological printing.

By Technology

Inkjet-based:

Inkjet-based bioprinting technology is widely recognized for its versatility and precision in depositing bio-inks to create complex tissue structures. This technique utilizes piezoelectric or thermal inkjet mechanisms to eject droplets of cell-laden materials onto a substrate. One of its primary advantages is the ability to achieve high-resolution prints with minimal waste of bio-ink, making it a cost-effective option for various applications. Inkjet bioprinting is particularly well-suited for generating vascular structures and tissue scaffolds, contributing significantly to advancements in tissue engineering and regenerative medicine.

Extrusion-based:

Extrusion-based bioprinting is characterized by its ability to continuously dispense bio-inks through a nozzle, allowing for the production of larger tissue constructs with high cell densities. This technology is commonly used for printing hydrogels and other viscous materials, making it ideal for creating bulk tissues and constructs that require structural integrity. The process enables the incorporation of a variety of materials, including living cells, growth factors, and biomaterials, which can be layered to construct complex three-dimensional architectures. The increasing demand for functional tissues has led to a surge in the adoption of extrusion-based bioprinting in recent years.

Laser-assisted:

Laser-assisted bioprinting employs focused laser beams to transfer bio-inks onto a substrate, allowing for high precision in constructing complex tissue patterns. This technology offers several advantages, including the ability to create structures with fine detail and minimal cellular damage during the printing process. The versatility of laser-assisted bioprinting makes it suitable for a variety of applications, such as creating intricate vascular networks and heterogeneous tissue structures. As researchers continue to explore the potential of this technology, its role in advancing tissue engineering and regenerative medicine is expected to grow significantly.

Magnetic Printing:

Magnetic printing technology utilizes magnetic fields to arrange and position living cells in specific patterns, allowing for the creation of complex tissue architectures. This innovative approach enables the incorporation of multiple cell types and biomaterials in a single print, promoting cell-cell interactions and enhancing tissue functionality. Magnetic printing also provides a unique advantage in terms of scalability, as it allows for the production of larger tissue constructs without compromising the precision of cell placement. As the demand for complex tissue structures increases, magnetic printing is anticipated to gain prominence in the 3D biological printing market.

Microvalve-based:

Microvalve-based bioprinting relies on a series of microvalves to control the precise deposition of bio-inks onto a substrate. This technology enables the printing of highly controlled patterns and allows for the incorporation of a wide range of materials, including living cells and growth factors. The ability to print multiple materials simultaneously enhances the potential for creating complex tissue structures that closely mimic the functionality of natural tissues. With ongoing advancements in microvalve technology, this approach is likely to see increased adoption in various applications, particularly in tissue engineering and drug discovery.

By Material Type

Hydrogels:

Hydrogels are among the most commonly used materials in 3D biological printing due to their excellent biocompatibility and ability to mimic the extracellular matrix. These water-based polymers can encapsulate living cells, providing a supportive environment for cell growth and tissue development. Their tunable mechanical properties and biodegradability make them ideal for a variety of applications, ranging from tissue engineering to drug delivery systems. As researchers continue to explore new hydrogel formulations, the demand for this material type in bioprinting is expected to grow significantly, particularly for regenerative medicine applications.

Living Cells:

Living cells are the core component of many bioprinting applications, enabling the fabrication of functional tissues and organoids. The ability to print different cell types in precise patterns allows researchers to create complex tissue architectures that closely resemble natural structures. Advances in cell encapsulation techniques and the development of specialized bio-inks are enhancing the viability and functionality of printed cells. The increasing demand for personalized medicine and tissue engineering solutions is driving the incorporation of living cells in bioprinting processes, further expanding this material segment within the market.

Biocompatible Polymers:

Biocompatible polymers are essential in 3D biological printing, as they provide a supportive scaffold for cell attachment and growth while ensuring compatibility with biological systems. These materials can be engineered to exhibit specific mechanical, chemical, and biological properties, making them suitable for various applications, including tissue engineering and regenerative medicine. The versatility of biocompatible polymers allows researchers to tailor their properties for specific tissues or organ systems, thereby enhancing the functionality of bioprinted constructs. As the demand for high-quality scaffolding materials continues to rise, the biocompatible polymers segment is expected to grow significantly.

Ceramic Inks:

Ceramic inks are primarily utilized in the production of bioceramics for applications in bone tissue engineering and dental restoration. These inks provide excellent mechanical strength and biocompatibility, allowing for the creation of scaffolds that can support bone regeneration. The ability to incorporate bioactive materials into ceramic inks further enhances their functionality, promoting cellular activities and accelerating the healing process. As the need for effective bone repair solutions continues to grow, the adoption of ceramic inks in 3D biological printing is anticipated to increase, contributing positively to market dynamics.

Metal Inks:

Metal inks are emerging as a vital material in 3D biological printing, particularly for applications in the field of implants and prosthetics. These inks allow for the fabrication of high-strength structures that can withstand mechanical loads while providing biocompatibility. The integration of metal components into bioprinted constructs can enhance their durability and longevity, making them ideal for applications in orthopedic and dental implants. As advancements in metal 3D printing technologies continue to evolve, the utilization of metal inks in the biological printing market is expected to expand significantly.

By User

Hospitals and Clinics:

Hospitals and clinics are key users of 3D biological printing technologies, primarily for applications in regenerative medicine and tissue engineering. This sector utilizes bioprinting to create patient-specific tissues, enhancing the chances of successful transplantation and improving overall patient outcomes. As healthcare providers increasingly recognize the advantages of personalized medicine, the adoption of bioprinting technologies within clinical settings is expected to grow. Additionally, hospitals are leveraging 3D bioprinted tissues for pre-surgical planning and training, further driving demand in this user segment.

Research Institutes:

Research institutes play a crucial role in advancing the field of 3D biological printing through rigorous experimentation and innovation. These institutions are often at the forefront of developing new bioprinting techniques and materials, contributing to the evolution of the technology. Collaboration between research institutes and industry stakeholders facilitates the translation of lab-based innovations into practical applications, thus accelerating the commercialization of bioprinting technologies. As the focus on research and development in this field intensifies, the demand for 3D biological printing technologies from research institutes is expected to rise significantly.

Pharmaceutical & Biotechnology Companies:

Pharmaceutical and biotechnology companies are increasingly adopting 3D biological printing technologies to enhance drug discovery and development processes. The ability to create intricate tissue models that mimic human biology allows these companies to evaluate drug responses and toxicity more accurately, thereby improving the efficiency of clinical trials. The integration of bioprinting technologies into drug development pipelines is expected to lead to more effective treatments and personalized therapies, driving further investment in this segment. As the pharmaceutical industry continues to innovate, the demand for bioprinting solutions is anticipated to increase substantially.

Academic Institutes:

Academic institutes are fundamental contributors to the growth of the 3D biological printing market, focusing on education and research in this emerging field. These institutions offer valuable insights into the underlying science of bioprinting, shaping the next generation of professionals and researchers. Furthermore, academic partnerships with industry stakeholders often result in groundbreaking research projects that push the boundaries of bioprinting technologies. As academic institutions continue to explore novel applications and improve existing techniques, their impact on the market is expected to grow significantly.

Food Industry:

The food industry is beginning to embrace 3D biological printing technologies for producing customized and sustainable food products. By leveraging bioprinting, food companies can create unique food structures that cater to specific consumer preferences and dietary needs. This innovative approach not only enhances product variety but also addresses sustainability concerns linked to traditional food production methods. As the demand for personalized and sustainable food options continues to rise, the food industry's adoption of 3D biological printing is expected to expand, contributing to market growth.

By Region

North America currently dominates the 3D biological printing market, reflecting a significant share of approximately 40% of the global market value. The region's strong emphasis on research and development, combined with the presence of leading biotechnology and pharmaceutical companies, fosters an environment conducive to innovation in bioprinting technologies. Moreover, increased government funding for healthcare initiatives and the growing prevalence of chronic diseases contribute to the robust growth of the market in North America. The region is projected to maintain its leading position, with a healthy CAGR of about 23% over the forecast period.

Europe follows closely behind North America, holding a substantial share of approximately 30% of the market. The European region benefits from a highly developed healthcare infrastructure and strong regulatory frameworks that support the adoption of advanced bioprinting technologies. Countries such as Germany, the UK, and France are at the forefront of research initiatives aimed at advancing the capabilities of 3D biological printing. As collaborations between academic institutions and industry stakeholders continue to enhance innovation, Europe is anticipated to experience steady growth, with a projected CAGR of 21% during the forecast period. The Asia Pacific region is expected to witness the fastest growth due to increasing investments in healthcare infrastructure and rising awareness of bioprinting applications.

Opportunities

The 3D biological printing market presents a wealth of opportunities driven by the increasing demand for personalized medicine. As healthcare becomes more patient-centric, the need for tailored solutions that address individual patient needs is on the rise. Bioprinting technologies offer the unique capability to create patient-specific tissues and organs, which could revolutionize the field of transplant medicine. Additionally, the expansion of telemedicine and remote healthcare services provides a platform for the integration of bioprinting technologies in various healthcare settings, enhancing accessibility to advanced medical solutions. As stakeholders recognize the potential of bioprinting for personalized treatments, investment and research in this area are expected to accelerate, leading to further innovations and market growth.

Moreover, the growing focus on sustainability and environmental responsibility offers opportunities for the 3D biological printing market to expand into food technology applications. As consumers become increasingly conscious of the ecological impact of traditional food production methods, 3D bioprinting presents a solution to create sustainable and customized food products that meet diverse dietary preferences. Companies can leverage bioprinting to produce innovative food structures while minimizing waste, thereby addressing consumer demand for sustainable options. This alignment with sustainability trends is poised to drive significant growth in the food technology segment of the 3D biological printing market.

Threats

Despite the promising growth potential of the 3D biological printing market, there are inherent threats that could hinder its progress. One significant challenge is the regulatory landscape surrounding bioprinting technologies, which is still evolving. The approval processes for bioprinted products can be lengthy and complex due to the need for comprehensive safety and efficacy evaluations. Regulatory uncertainties may deter investment and slow down the commercialization of bioprinted products, limiting the market's growth. Additionally, variability in standards and regulations across different regions presents challenges for companies seeking to expand internationally, potentially leading to delays and increased costs in product development and marketing.

Furthermore, the high costs associated with advanced bioprinting technologies and materials can serve as a restraining factor for smaller companies and startups. The need for specialized equipment and expertise to develop and implement bioprinting processes can create barriers to entry, inhibiting competition within the market. Additionally, the fast-paced advancements in technology may lead to obsolescence for those unable to keep up with the latest innovations. As the market evolves, companies must invest significantly in research and development to remain competitive, which could strain resources for some players.

Competitor Outlook

• Organovo Holdings, Inc.
• 3D Biotek LLC
• Aspect Biosystems Ltd.
• Cellink AB
• Regenhu Ltd.
• Biolife Solutions, Inc.
• Materialise NV
• EnvisionTEC, Inc.
• Allevi, Inc.
• Stratasys Ltd.
• OxSyBIO Ltd.
• Poietis SA
• Cyfuse Biomedical K.K.
• Fabrica S.r.l.
• Nano3D Biosciences, Inc.

The overall competitive landscape of the 3D biological printing market is characterized by the presence of numerous players ranging from established companies to innovative startups. The market is driven by technological advancements, strategic collaborations, and a continuous focus on research and development. Established firms are leveraging their extensive expertise and resources to enhance their product offerings, while emerging players are focusing on niche applications and novel bioprinting solutions. The competition is intensified by the growing interest in personalized medicine, regenerative therapies, and sustainable food technologies, leading companies to differentiate their products through innovation and quality.

Organovo Holdings, Inc. is a pioneer in the 3D biological printing space, specializing in bioprinted human tissues for drug discovery and disease modeling. The company has developed proprietary technology to create multi-cellular tissue structures, enabling researchers to better understand human biology and improve drug testing processes. With a strong emphasis on innovation and collaboration, Organovo is at the forefront of advancing bioprinting applications in various sectors. Additionally, 3D Biotek LLC focuses on providing bioprinting solutions for tissue engineering and regenerative medicine, offering a range of bio-inks and printing systems tailored for specific applications.

Companies like Cellink AB and Materialise NV are also significant players in the market, offering a diverse range of bioprinting technologies and materials. Cellink has gained recognition for its bio-ink products, which are designed to support cell growth and mimic the extracellular matrix, while Materialise provides comprehensive solutions for 3D printing, including software and hardware for biomedical applications. With a strong presence in the global market, these companies continue to drive innovation and enhance the capabilities of bioprinting technologies.

• 1 Appendix

  • 1.1 List of Tables
  • 1.2 List of Figures

• 2 Introduction

  • 2.1 Market Definition
  • 2.2 Scope of the Report
  • 2.3 Study Assumptions
  • 2.4 Base Currency & Forecast Periods

• 3 Market Dynamics

  • 3.1 Market Growth Factors
  • 3.2 Economic & Global Events
  • 3.3 Innovation Trends
  • 3.4 Supply Chain Analysis

• 4 Consumer Behavior

  • 4.1 Market Trends
  • 4.2 Pricing Analysis
  • 4.3 Buyer Insights

• 5 Key Player Profiles

  • 5.1 Cellink AB
    • 5.1.1 Business Overview
    • 5.1.2 Products & Services
    • 5.1.3 Financials
    • 5.1.4 Recent Developments
    • 5.1.5 SWOT Analysis
  • 5.2 Poietis SA
    • 5.2.1 Business Overview
    • 5.2.2 Products & Services
    • 5.2.3 Financials
    • 5.2.4 Recent Developments
    • 5.2.5 SWOT Analysis
  • 5.3 Allevi, Inc.
    • 5.3.1 Business Overview
    • 5.3.2 Products & Services
    • 5.3.3 Financials
    • 5.3.4 Recent Developments
    • 5.3.5 SWOT Analysis
  • 5.4 OxSyBIO Ltd.
    • 5.4.1 Business Overview
    • 5.4.2 Products & Services
    • 5.4.3 Financials
    • 5.4.4 Recent Developments
    • 5.4.5 SWOT Analysis
  • 5.5 Regenhu Ltd.
    • 5.5.1 Business Overview
    • 5.5.2 Products & Services
    • 5.5.3 Financials
    • 5.5.4 Recent Developments
    • 5.5.5 SWOT Analysis
  • 5.6 3D Biotek LLC
    • 5.6.1 Business Overview
    • 5.6.2 Products & Services
    • 5.6.3 Financials
    • 5.6.4 Recent Developments
    • 5.6.5 SWOT Analysis
  • 5.7 Fabrica S.r.l.
    • 5.7.1 Business Overview
    • 5.7.2 Products & Services
    • 5.7.3 Financials
    • 5.7.4 Recent Developments
    • 5.7.5 SWOT Analysis
  • 5.8 Materialise NV
    • 5.8.1 Business Overview
    • 5.8.2 Products & Services
    • 5.8.3 Financials
    • 5.8.4 Recent Developments
    • 5.8.5 SWOT Analysis
  • 5.9 Stratasys Ltd.
    • 5.9.1 Business Overview
    • 5.9.2 Products & Services
    • 5.9.3 Financials
    • 5.9.4 Recent Developments
    • 5.9.5 SWOT Analysis
  • 5.10 EnvisionTEC, Inc.
    • 5.10.1 Business Overview
    • 5.10.2 Products & Services
    • 5.10.3 Financials
    • 5.10.4 Recent Developments
    • 5.10.5 SWOT Analysis
  • 5.11 Aspect Biosystems Ltd.
    • 5.11.1 Business Overview
    • 5.11.2 Products & Services
    • 5.11.3 Financials
    • 5.11.4 Recent Developments
    • 5.11.5 SWOT Analysis
  • 5.12 Cyfuse Biomedical K.K.
    • 5.12.1 Business Overview
    • 5.12.2 Products & Services
    • 5.12.3 Financials
    • 5.12.4 Recent Developments
    • 5.12.5 SWOT Analysis
  • 5.13 Biolife Solutions, Inc.
    • 5.13.1 Business Overview
    • 5.13.2 Products & Services
    • 5.13.3 Financials
    • 5.13.4 Recent Developments
    • 5.13.5 SWOT Analysis
  • 5.14 Organovo Holdings, Inc.
    • 5.14.1 Business Overview
    • 5.14.2 Products & Services
    • 5.14.3 Financials
    • 5.14.4 Recent Developments
    • 5.14.5 SWOT Analysis
  • 5.15 Nano3D Biosciences, Inc.
    • 5.15.1 Business Overview
    • 5.15.2 Products & Services
    • 5.15.3 Financials
    • 5.15.4 Recent Developments
    • 5.15.5 SWOT Analysis

• 6 Market Segmentation

  • 6.1 3D Biological Printing Market, By User
    • 6.1.1 Hospitals and Clinics
    • 6.1.2 Research Institutes
    • 6.1.3 Pharmaceutical & Biotechnology Companies
    • 6.1.4 Academic Institutes
    • 6.1.5 Food Industry
  • 6.2 3D Biological Printing Market, By Technology
    • 6.2.1 Inkjet-based
    • 6.2.2 Extrusion-based
    • 6.2.3 Laser-assisted
    • 6.2.4 Magnetic Printing
    • 6.2.5 Microvalve-based
  • 6.3 3D Biological Printing Market, By Application
    • 6.3.1 Tissue Engineering
    • 6.3.2 Regenerative Medicine
    • 6.3.3 Drug Discovery
    • 6.3.4 Biosensors
    • 6.3.5 Food Technology
  • 6.4 3D Biological Printing Market, By Material Type
    • 6.4.1 Hydrogels
    • 6.4.2 Living Cells
    • 6.4.3 Biocompatible Polymers
    • 6.4.4 Ceramic Inks
    • 6.4.5 Metal Inks

• 7 Competitive Analysis

  • 7.1 Key Player Comparison
  • 7.2 Market Share Analysis
  • 7.3 Investment Trends
  • 7.4 SWOT Analysis

• 8 Research Methodology

  • 8.1 Analysis Design
  • 8.2 Research Phases
  • 8.3 Study Timeline

• 9 Future Market Outlook

  • 9.1 Growth Forecast
  • 9.2 Market Evolution

• 10 Geographical Overview

  • 10.1 Europe - Market Analysis
    • 10.1.1 By Country
      • 10.1.1.1 UK
      • 10.1.1.2 France
      • 10.1.1.3 Germany
      • 10.1.1.4 Spain
      • 10.1.1.5 Italy
  • 10.2 Asia Pacific - Market Analysis
    • 10.2.1 By Country
      • 10.2.1.1 India
      • 10.2.1.2 China
      • 10.2.1.3 Japan
      • 10.2.1.4 South Korea
  • 10.3 Latin America - Market Analysis
    • 10.3.1 By Country
      • 10.3.1.1 Brazil
      • 10.3.1.2 Argentina
      • 10.3.1.3 Mexico
  • 10.4 North America - Market Analysis
    • 10.4.1 By Country
      • 10.4.1.1 USA
      • 10.4.1.2 Canada
  • 10.5 Middle East & Africa - Market Analysis
    • 10.5.1 By Country
      • 10.5.1.1 Middle East
      • 10.5.1.2 Africa
  • 10.6 3D Biological Printing Market by Region

• 11 Global Economic Factors

  • 11.1 Inflation Impact
  • 11.2 Trade Policies

• 12 Technology & Innovation

  • 12.1 Emerging Technologies
  • 12.2 AI & Digital Trends
  • 12.3 Patent Research

• 13 Investment & Market Growth

  • 13.1 Funding Trends
  • 13.2 Future Market Projections

• 14 Market Overview & Key Insights

  • 14.1 Executive Summary
  • 14.2 Key Trends
  • 14.3 Market Challenges
  • 14.4 Regulatory Landscape

Segments Analyzed in the Report

The global 3D Biological Printing market is categorized based on

By Application

• Tissue Engineering
• Regenerative Medicine
• Drug Discovery
• Biosensors
• Food Technology

By Technology

• Inkjet-based
• Extrusion-based
• Laser-assisted
• Magnetic Printing
• Microvalve-based

By Material Type

• Hydrogels
• Living Cells
• Biocompatible Polymers
• Ceramic Inks
• Metal Inks

By User

• Hospitals and Clinics
• Research Institutes
• Pharmaceutical & Biotechnology Companies
• Academic Institutes
• Food Industry

By Region

• North America
• Europe
• Asia Pacific
• Latin America
• Middle East & Africa

Key Players

• Organovo Holdings, Inc.
• 3D Biotek LLC
• Aspect Biosystems Ltd.
• Cellink AB
• Regenhu Ltd.
• Biolife Solutions, Inc.
• Materialise NV
• EnvisionTEC, Inc.
• Allevi, Inc.
• Stratasys Ltd.
• OxSyBIO Ltd.
• Poietis SA
• Cyfuse Biomedical K.K.
• Fabrica S.r.l.
• Nano3D Biosciences, Inc.